BAUSCH HEALTH COMPANIES INC/ CA0717341071 /

6/24/2022 10:00:01 PM	Chg. +1.83	Volume	Bid10:14:59 PM	Ask10:14:59 PM	Market Capitalization	Dividend Y.	P/E Ratio
11.28CAD	+19.37%	1.64 mill. Turnover: 17.93 mill.	11.00Bid Size: 500	11.30Ask Size: 700	4.02 bill.CAD	-	-

GlobeNewswire 3/29 Lantheus Announces Collaboration to Support Prostate Cancer Clinical Development

GlobeNewswire 3/28 Eyenovia Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 3/8 Lantheus Holdings to Present at the Barclays Global Healthcare Conference

GlobeNewswire 3/8 Inozyme Pharma Strengthens Management Team with Two Executive Appointments

GlobeNewswire 3/7 EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer

GlobeNewswire 3/3 Lantheus to Host Inaugural Investor Day

GlobeNewswire 3/1 Lantheus Announces Appointment of Minnie Baylor-Henry as New Board Member

GlobeNewswire 2/24 Palette Life Sciences Enters Into an Agreement with Lantheus to Support the Promotion of PYLARIFY® (...

GlobeNewswire 2/24 Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2/23 Nicox Announces VYZULTA Now Commercialized in 7 Territories and Approved in Further 9 Countries

GlobeNewswire 2/10 Lantheus Announces Presentation Featuring PYLARIFY® (Piflufolastat F18) at the 2022 ASCO GU Meeting

GlobeNewswire 2/10 Lantheus Holdings to Host Fourth Quarter and Full Year 2021 Earnings Conference Call and Webcast on ...

GlobeNewswire 1/27 Lantheus Collaborates with The Prostate Cancer Clinical Trial Consortium (PCCTC) To Advance AI-Enabl...

GlobeNewswire 12/1/2021 Lantheus Appoints Vivian Yao as Chief Human Resources Officer

GlobeNewswire 11/29/2021 Lantheus Announces PYLARIFY AI™ is Now Available

GlobeNewswire 11/29/2021 Journey Medical Corporation Introduces Expanded Board of Directors

GlobeNewswire 11/22/2021 Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F 18) I...

GlobeNewswire 11/17/2021 Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its PSMA-Targete...

GlobeNewswire 11/17/2021 Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe

GlobeNewswire 11/16/2021 Lantheus Holdings to Present at the 4th Annual Evercore ISI HealthCONx Conference

GlobeNewswire 11/16/2021 Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy...

GlobeNewswire 11/10/2021 Eyenovia Reports Third Quarter 2021 Financial Results

GlobeNewswire 11/4/2021 Eyenovia Announces First Patient Enrolled in Phase 3 VISION-2 Trial of MicroLine for Presbyopia

GlobeNewswire 11/4/2021 Lantheus Holdings, Inc. Reports Third Quarter 2021 Financial Results

GlobeNewswire 10/28/2021 Lantheus Holdings to Present at Upcoming Investor Conferences